• Cellect Biotechnology Ltd. APOP shares surged 24.7 percent to $5.20. Cellect Biotech disclosed that it has treated the first blood cancer patient in Phase I/II trial of ApoGraft
  • Kforce Inc. KFRC shares climbed 21.1 percent to $25.85 after the company reported better-than-expected Q4 earnings. Avondale Partners upgraded Kforce from Market Perform to Outperform.
  • Wecast Network Inc WCST shares rose 20.4 percent to $1.91.
  • Aehr Test Systems AEHR surged 18.6 percent to $2.62 as the company disclosed that it has received an order from a subcontractor to its lead customer for its FOX-XP test and burn-in system products.
  • Coherent, Inc. COHR shares climbed 17.5 percent to $189.63 after the company reported better-than-expected Q1 earnings.
  • Lumentum Holdings Inc LITE jumped 14.9 percent to $46.18 on better-than-expected quarterly earnings.
  • Diffusion Pharmaceuticals Inc DFFN shares surged 14.8 percent to $5.03. Diffusion Pharmaceuticals disclosed that TSC Phase 1/2 glioblastoma multiforme clinical trial results has been published in the February 2017 edition of Journal of Neurosurgery.
  • Foundation Medicine Inc FMI shares climbed 13.1 percent to $24.77 in pre-market trading after surging 12.31 percent on Tuesday. Foundation Medicine will release its quarterly earnings on February 22, 2017.
  • Caesarstone Ltd CSTE gained 12.7 percent to $33.80. Caesarstone reported Q4 adjusted earnings of $0.53 per share on revenue of $135 million.
  • Universal Corp UVV climbed 12 percent to $78.90. Universal Corp reported FQ3 net income of $53.6 million on revenue of $668.8 million.
  • OncoSec Medical Inc ONCS rose 11.7 percent to $1.32. OncoSec disclosed that it will present new clinical data from its Phase 2 combination study at ASCO-SITC Clinical Immuno-Oncology Symposium.
  • Jive Software Inc JIVE gained 10.8 percent to $4.38 after the company posted upbeat quarterly results.
  • Walker & Dunlop, Inc. WD shares surged 10.6 percent to $35.50 after the company posted strong Q4 results.
  • Myriad Genetics, Inc. MYGN gained 10.6 percent to $17.03 after the company posted upbeat Q2 results and narrowed its FY17 adjusted earnings outlook. Ladenburg Thalmann upgraded Myriad Genetics from Sell to Neutral.
  • ScanSource, Inc. SCSC shares climbed 10 percent to $44.08 on stronger-than-expected quarterl
  • y earnings.
  • Microchip Technology Inc. MCHP rose 7.6 percent to $74.90 after the company reported upbeat Q3 results and issued a strong Q4 outlook. Needham upgraded Microchip from Buy to Strong Buy.
  • Momo Inc (ADR) MOMO gained 7.5 percent to $24.48. Jefferies initiated coverage of Momo with a Buy rating.
  • Thor Industries, Inc. THO rose 4.7 percent to $109.38. Baird upgraded Thor Industries from Neutral to Outperform.
  • Vanda Pharmaceuticals Inc. VNDA rose 4.1 percent to $14.20. Vanda Pharmaceuticals is expected to announce Q4 financial results on February 15, 2017.
  • Cognizant Technology Solutions Corp CTSH shares rose 3.7 percent to $55.76 after the company posted upbeat quarterly earnings and reported a cooperation agreement with Elliott Management.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!